These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2698084)

  • 21. [The role of immunization against bacterial enteric infections (author's transl)].
    Rey M
    Med Trop (Mars); 1979; 39(4):457-62. PubMed ID: 537492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
    Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
    J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The action of ribosomal preparations on nonspecific resistance to bacterial infection and on early tolerance to endotoxic shock].
    Belkin ZP; Levenson VI; Egorova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):47-50. PubMed ID: 1882607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local and systemic immunity after typhoid vaccines.
    Tagliabue A; Villa L; Boraschi D; Nencioni L
    Ann Sclavo Collana Monogr; 1986; 3(1-2):31-9. PubMed ID: 3322341
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunization of goats for the production of diagnostic sera capable of agglutinating Salmonella typhi O, Salmonella typhi H and Shigella flexneri].
    TUROWSKA B; SOBOL A
    Med Dosw Mikrobiol; 1961; 13():279-84. PubMed ID: 13778764
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans.
    Forrest BD; LaBrooy JT; Attridge SR; Boehm G; Beyer L; Morona R; Shearman DJ; Rowley D
    J Infect Dis; 1989 Jan; 159(1):145-6. PubMed ID: 2909633
    [No Abstract]   [Full Text] [Related]  

  • 31. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New enteric vaccines: application of new knowledge of receptors and recognition in enteric infections.
    Candy DC
    Trans R Soc Trop Med Hyg; 1985; 79(5):577-80. PubMed ID: 3913065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development of a bivalent vaccine against diarrhoeal disease.
    Forrest BD
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):449-57. PubMed ID: 2464195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rational design of Salmonella recombinant vaccines.
    Cheminay C; Hensel M
    Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a.
    Dearlove CE; Forrest BD; van den Bosch L; La Brooy JT
    J Infect Dis; 1992 Jan; 165(1):182-3. PubMed ID: 1727891
    [No Abstract]   [Full Text] [Related]  

  • 38. The rpoS mutant allele of Salmonella typhi Ty2 is identical to that of the live typhoid vaccine Ty21a.
    Robbe-Saule V; Norel F
    FEMS Microbiol Lett; 1999 Jan; 170(1):141-3. PubMed ID: 9919662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine.
    Kollaritsch H; Que JU; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1997 Apr; 175(4):871-5. PubMed ID: 9086143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Typhoid fever as cellular microbiological model.
    de Andrade DR; de Andrade Júnior DR
    Rev Inst Med Trop Sao Paulo; 2003; 45(4):185-91. PubMed ID: 14502344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.